General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Carta(NONE) OTHER FINANCIAL BENEFIT: HealthPals(SIGNIFICANT)

View Full Disclosure